Matthews International Capital Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Matthews International Capital Management’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-478,218	Closed	-$13.1M	–	41
2015 Q1	$13.1M	Sell	478,218 -220,800	-32%	-$6.08M	0.46%	19
2014 Q4	$18.5M	Sell	699,018 -282,500	-29%	-$8.27M	0.77%	15
2014 Q3	$29.6M	Sell	981,518 -42,100	-4%	-$1.3M	1.37%	11
2014 Q2	$32.2M	Hold	1,023,618	–	–	1.8%	9
2014 Q1	$33.1M	Hold	1,023,618	–	–	1.85%	9
2013 Q4	$37.2M	Buy	1,023,618 +27,600	+3%	+$1.07M	1.87%	9
2013 Q3	$38.7M	Sell	996,018 -134,600	-12%	-$5.42M	1.98%	9
2013 Q2	$42.3M	Buy	+1,130,618	New	+$44.6M	2.37%	9

Other funds holding MR

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

GAM

Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CCMH

Cornerstone Capital Management Holdings New York $14.3B AUM 33.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Matthews International Capital Management's MR Position: Q2 2015 in Review

Matthews International Capital Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2015, closing a stake of 478,218 shares — an estimated $13.1M sold.

Matthews International Capital Management first reported a position in MR in Q2 2013 and held it in 8 quarters. The position peaked at $42.3M in Q2 2013. 118 funds tracked by Wall St. Rank hold MR as of Q2 2015.

Matthews International Capital Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2015 after selling out during the quarter.
Matthews International Capital Management sold 478,218 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2015, an estimated $13.1M.
Matthews International Capital Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 8 quarters.
Matthews International Capital Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $42.3M in Q2 2013.
118 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2015.

Based on Matthews International Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.